Black Diamond Therapeutics, Inc. (BDTX) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts BDTX Hot Sheet
Join SI Premium – FREE
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) reported Q4 EPS of ($0.27), $0.10 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Black Diamond Therapeutics, Inc. (BDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
